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Summary
Objectives: To assess patient satisfaction with bone-anchored hearing aids (BAHA) and the
role of preoperative audiometric testing.
Patients and methods: A telephone satisfaction survey was conducted on all patients implanted
between June 1, 2005 and February 1, 2008. Patients with unilateral total deafness underwent
preoperative audiometric tests in quiet and in noise and stereoaudiometry with and without
BAHA. Patients with a conductive hearing loss underwent preoperative audiometric tests in
quiet and in noise and real-life testing at home using a headband. A standardized satisfaction
questionnaire derived from the Entiﬁc BAHA questionnaire was used.
Results: Twenty-two out of 26 patients responded to the questionnaire. Ten patients were
implanted for conductive hearing loss (CHL) and 12 for unilateral total deafness (UTD). Mean
follow-up was 19 months in the UTD group and 21 months in the CHL group. Sixty-seven percent
of UTD and 80% of CHL patients reported improved quality of life. The BAHA was worn for more
than 4 hours per day by 83% of UTD and 100% of CHL patients, and at least 5 days per week by
67% of UTD and 80% of CHL patients.
Conclusion: BAHAs provided real beneﬁt in all situations for CHL patients. In UTD, its beneﬁt
basically related to noisy environments. In UTD, satisfaction on preoperative stereoaudiometric
testing in noise with and without BAHA was predictive of postimplantation satisfaction. In
response to the question ‘‘Would you do it again?’’, 81% of patients answered ‘‘Yes’’.
© 2011 Elsevier Masson SAS. All
∗ Corresponding author.
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he idea of auditory rehabilitation using a bone-anchored
earing aid (BAHA) was born in 1977 and ﬁrst reported by
served.
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jellström et al. [1,2]. The technique had been made pos-
ible thanks to Per-Ingvar Bränemark’s work in the 1960s
n the osseointegration of titanium implants, ﬁrst in ani-
als and then in the human oral cavity. BAHA was the ﬁrst
ttempt at bone-anchored implantation outside of the oral
avity. The concept developed by the technique’s precursors
as to stimulate the cochlea by bone conduction. Although
escribed more than a century ago, the physiology of this
atural auditory pathway is still not fully understood. Von
ékésy’s experiments [3] on bone conduction showed that
irect excitation of the cranium by a vibrator induces the
ame cochlear auditory transduction mechanisms as in air
ransmission [4]. Three bone conduction pathways are well
nown: relative movement of ossicles and temporal bone,
one compression, and sound radiating in the external ear
anal. Sohmer and Freeman, in 2000 [5] and again in 2004
6], described a new bone conduction pathway via the cere-
rospinal ﬂuid and cerebral soft tissue.
Indications for BAHA were initially conductive hearing
oss (CHL) secondary to chronic otitis, non-amenable to
anagement by conventional hearing aids (HA) or secondary
o congenital middle or external ear malformation [7—9]:
he use of BAHA does not presuppose tympano-ossicular
ystem integrity. It has proved more effective in CHL than
lassical HAs that use bone conduction by simple contact of
vibrator against the skin [10]. Being anchored in the bone,
he implant creates its own pathway, known as a direct
one conduction pathway, free of attenuation induced by
he skin and subcutaneous soft tissue, which represents
gain of some 15 dB at conversation frequencies. [9].
ore recently, indications for BAHA have been extended
o unilateral total deafness (UTD) [11,12]. UTD is disabling
or the understanding of speakers situated on the deaf side
nd of speech in noise. The BAHA overcomes the shadowing
ffect of the head by picking up sound on the deaf side
nd conducting it via a bone pathway to the hearing side.
hus a sound presented to a BAHA-equipped UTD subject
s perceived by the healthy contralateral cochlea as two
istinct acoustic signals, one from the implant via bone
onduction and the other from the healthy ear; this artiﬁcial
ifference mimics physiological interaural difference.
The present study ﬁrstly investigated the beneﬁt pro-
ided by BAHAs, in a satisfaction and quality of life survey.
esults analysis took account of the underlying indication
conduction hearing loss or UTD). Secondly, the usefulness of
reoperative audiometric testing for patient selection was
ssessed.
atients and methods
atients ﬁtted with a BAHA were recruited via the insti-
ution’s data coding system. All were implanted between
une 1, 2005 and February 1, 2008. The study was two-
old: a retrospective records analysis, and a telephone
urvey using a standardized questionnaire based on the
ntiﬁc Medical Systems questionnaire. This questionnaire
uantiﬁes daily BAHA use in various situations and assesses
esultant satisfaction and improvement in quality of life, on
numerical satisfaction scale [13] to which items on ease
f HA handling were added, along with a ﬁnal question:
‘Would you do it again?’’ (Appendix 1).
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UTD patients underwent the following stereoaudiometric
ssessment [14]:
vocal audiometry with two-syllable word lists in 65 dB
HL noise (frontal white noise). Acoustic stimulus inten-
sity levels were 60, 65 and 70 dB (voice source at 90◦
azimuth to the affected side [simpliﬁed Hirsh test]) with
and without BAHA held by headband to the affected side;
multidirectional HA gain test (tonal audiometry on ﬁve
azimuths with and without BAHA held by head-band
[Dehaussy test]);
spatial location test (Decroix test).
CHL patients (group CHL) did not systematically undergo
tereoaudiometry, but were in all cases assessed by:
tonal audiometry;
vocal audiometry with two-syllable word lists;
open-ﬁeld vocal audiometry with two-syllable word lists,
with BAHA;
real-life testing, using a headband worn at home for 2
weeks.
When an HA was already being worn, tests were repeated
ith and without HA.
Stereoaudiometry was considered positive if the mean
ocal score in noise on the simpliﬁed Hirsh test exceeded 10%
r if a mean vocal score in noise of less than 50% passed the
0% threshold with use of BAHA. These values were chosen
y analogy to Hirsh test values for normal subjects, where
eparating voice and disturber sources improves mean vocal
core by 10 to 25% [14].
Implantation was indicated for UTD patients if stereoau-
iometry was positive or patient demand was strong, and
or CHL patients if the real-life trial proved beneﬁcial.
The same surgical procedure was performed in all 26
atients: a classical technique [15] involving a C-shaped ﬂap
ithout use of dermatome. The HA was implemented as of
months postoperatively.
esults
wenty-six patients were identiﬁed from the institution’s
urgery coding system: 11 male, 15 female; mean age
7± 18 yrs, median 46.5 yrs, range 7—77 yrs.
Indications for implantation were:
UTD (group UTD) in 14 cases (54%): three discovered
in childhood, ﬁve secondary to vestibular schwannoma,
three post-traumatic, one Menière’s disease, one post-
meningitis, and one secondary to otospongiosis surgery;
CHL (group CHL) in 12 cases (46%): 10 chronic otitis seque-
lae, one following ear exclusion for external auditory
canal carcinoma, and one severe unilateral aplasia.
Twenty-two of the 26 patients were contacted and
esponded to the questionnaire. Those not contacted
omprised: two cases of extrusion of the percutaneous abut-
ent, one HA removal at the patient’s request, and one lost
o follow-up (FU).
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20—77 yrs); mean FU, 21± 9 months.Figure 1 BAHA use: days per week.
Mean FU was 20± 9 months (range, 3months to 2 yrs
10months).
Frequency of BAHA use
In group UTD
Twelve patients answered the questionnaire: ﬁve women
and seven men; mean age 41.2± 16.1 years, range 7 to
67 yrs; mean FU, 19± 7.5 mo.
Eight patients (67%) used their BAHA every day, and nine
(75%) for more than 8 hours a day. Two patients (17%) did not
use it at all (Figs. 1 and 2).
In response to the question ‘‘Has your quality of life
improved because of the new device?’’, eight patients (67%)
answered positively. The mean score for the BAHA on the
QoL grading scale was 6.9/10 with a median of 8/10.Improvement in different situations was moderate to
good overall, with better results for one-to-one conversa-
tion, and a tendency for results to be less good for watching
m
w
Figure 3 BAHA beneﬁt according to situation. Person: 1-to-1; Gr
listening to television and/or radio.Figure 2 BAHA use: hours per day.
elevision or listening to the radio or in a group situation
Fig. 3).
In response to the question ‘‘In which situation is the
AHA most useful?’’, no UTD patients responded ‘‘In all
hese situations’’. The BAHA rarely proved useful to UTD
atients when they were alone at home (in the ‘‘real-life’’
est situation) (18%).
Conversely, in response to the question ‘‘In which situa-
ion is the BAHA not useful?’’, UTD patients always reported
here being situations in which the BAHA provided no bene-
t; for 58% of UTD patients, this was the ‘‘alone at home’’
ituation.
n group CHL
en patients responded to the questionnaire: seven women
nd three men; mean age, 54.5± 17.9 years (range,The BAHA was very well used, 100% of patients using it
ore than 4 hours a day and 80% using it at least 5 days a
eek (Figs. 1 and 2).
oup: group conversation; Music: listening to music; TV/radio:
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Another way of showing the interest of BAHAs is to assessigure 4 Complete bone-anchor component (cutaneous abut-
ent and osteoﬁxture) after wound healing.
Eighty percent of CHL patients reported improved quality
f life. The mean score for the BAHA on the QoL satisfac-
ion grading scale was 8.5/10. Results were very good to
xcellent in all situations for most patients, except in the
‘group’’ situation, where they were moderate (Fig. 3).
sthetic experience and handling
eventy-six percent of patients found the BAHA discreet,
ne even ﬁnding it nice; no one was bothered by its esthetic
spect, but 19% found it not very discreet. Fifty-eight per-
ent thought it looked nicer than a classical HA. The way it
an be hidden under the hair was very well received (Fig. 4).
Handling was reported to be easy or very easy in 73% of
ases (16/22); 27% graded it between ‘‘okay’’ and ‘‘very
ifﬁcult’’. The mean age of those not ﬁnding the BAHA easy
o handle was 60 years (median, 67 yrs). Daily maintenance
as judged demanding by one patient; two reported never
oing any maintenance.
omparison between preoperative audiometry
ata and overall postoperative satisfaction
n group UTD
ound discrimination in noise was the determining factor
n the indication. The tests of 10 of the 14 UTD patients
ere analyzed (two others could not be found, and two were
erformed elsewhere than our center). Eight showed more
han 10% improvement in intelligibility in noise as deﬁned
y the simpliﬁed Hirsh test, with in all cases a mean vocal
core in noise better than 50% using the BAHA. Mean satis-
action score was 8.4/10 on the questionnaire. Two patients
ere implanted despite non-satisfactory test results, as they
eported subjective improvement on testing: one with UTD
iscovered in childhood (intelligibility in noise improved by
%, but with a satisfaction score on the questionnaire of
/10), and one whose initial test was at the borderline for
ositive, with 10% improvement in intelligibility in noise, but
very bad satisfaction score of 1/10.
p
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n group CHL
ir-conduction tonal audiometry thresholds in the implanted
ar varied from 68dB to 120 dB loss: given the thresholds
n these extreme cases, audiometry was performed twice,
ith appropriate masking, to be sure of the presence of a
ochlear reserve. Bone-conduction thresholds varied from
0 to 57.5 dB loss. Mean conduction loss was 49.32 dB (range,
3 to 65 dB). Overall satisfaction was excellent, with a
ean score of 8.7/10 and a median of 10. One patient
cored his satisfaction at 1/10: he had been implanted after
ailure of iterative ossiculoplasty for chronic otitis, with air-
onduction thresholds of −75 dB in the implanted ear and
47.5 dB contralaterally and a conduction loss of 51.5 dB.
e made little use of the BAHA, although he found it use-
ul in one-to-one discussion and when watching television or
istening to music. His BAHA broke down twice, which may
ccount for his dissatisfaction.
iscussion
n studying the results, two important points emerged from
he present series: the satisfaction obtained with the BAHA
as considerable for both conductive hearing-loss and UTD
atients. A large majority of those satisﬁed with their BAHA
n the preoperative trial were also satisﬁed postoperatively.
The patients surveyed were satisﬁed with their BAHA, in
greement with other reports.
In the CHL group, the mean satisfaction score was 8.5/10,
n agreement with the series reported by Hakansson et al.
16] (mean, 8.7/10) and Badran et al. [17] (mean, 8.2/10).
t is well established that daily and weekly HA use time cor-
elates with beneﬁt. The present series showed a high level
f use (100% > 4 hours per day and 80% > 4 days per week),
s reported elsewhere: 93% of patients using their BAHA
veryday according to Dutt et al. [13] and 81% according
o Badran et al. [17]. Daily use was similar to that in other
eries: more than 4 hours a day in 78% of cases according to
azen [18], in 87% according to Tjellström [9] and in more
han 90% according to Hakansson [16] and Dutt [13]. This
evel of use was also reported to be sustained, at more than
0 hours per day more than 10 years after implantation [18].
Ninety percent of patients found the BAHA good or
xcellent in one-to-one conversation, versus 20% in group
iscussion. This large difference is found in all studies: 85%
s. 45% according to Badran [17], 94% vs. 49% according to
akansson [16], and 84% vs. 67% according to Dutt [13].
or use with music, television and radio, satisfaction scores
ere moderate; very few patients chose either ‘‘excellent’’
r ‘‘very bad’’ as responses: only 10% with respect to music,
nd 20% with respect to the radio. Even so, the BAHA was
seful: 80% found it moderately useful for listening to music
nd 60% for watching television. It was less effective in such
ituations than in one-to-one conversation, but nevertheless
seful. This was conﬁrmed in other series, in which satisfac-
ion with BAHA with respect to music or radio was high: e.g.,
6% of ‘‘very good’’ or ‘‘excellent’’ responses for Badran
17] and 74% for Hakansson [16].erceived usefulness across situations: most patients ﬁnd
heir BAHA useful in ‘‘all situations’’, and very few ﬁnd it
‘never useful’’.
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—Patient satisfaction and functional results with the bone-anc
Finally, 80% of conductive hearing-loss patients reported
improved quality of life with the use of their BAHA.
In the UTD group, the mean satisfaction score was
6.9/10: i.e., lower than in the CHL group. This is in agree-
ment with other reports. Tringali [19] reported a score of
6.2/10 in the largest series published (n = 118), with a differ-
ence between CHL and USD groups much like in the present
series: satisfaction 8.11 in CHL. Daily use exceeded 8 hours
a day in 67% of cases and 4 hours a day in 75%. These results
are slightly better than those reported by Tringali (48.5% > 8
hr/day and 81.5% > 4 hr/day) but lower than those usually
found in the literature (78% > 8 hr/day for Hol [20] and 94%
for Wazen [21]). This was due to our follow-up being longer
than Hol’s [20], and the fact that Wazen’s [21] patients
answered their questionnaire 1 month after implantation;
but our series was much smaller than Tringali’s [19].
In UTD, BAHAs are especially useful in group discussion,
where sound may be coming from various speakers and
directions, whereas they are mostly considered ‘‘not
useful’’ by UTD patients when they are alone. Thus, while
BAHAs do not restore true stereophonics, since the source
of the sound cannot be located, perception in noise is
nevertheless improved [22]. The satisfaction level for the
use of BAHAs in group situations was higher in UTD than in
CHL patients: 20% ‘‘very good’’ or ‘‘excellent’’ responses
from CHL patients, versus 33% from UTD patients. The
implant is useful in such situations.
Results regarding BAHA esthetics were very good: 75%
of the patients found it discreet. It can easily be hidden
in the hair. No psychological difﬁculty in wearing a visible
bone-anchored implant emerged (Fig. 4). No patients in the
present series reported any problems related to wearing a
hat, unlike in the literature. It should be noted that the
percutaneous abutment should be positioned low down in
patients who wear hats.
Day-to-day use of BAHAs is easy: 73% of patients found
them ‘‘easy’’ or ‘‘very easy’’ to handle. Acquisition was easy
and quick for most patients, but gets harder with age: the six
patients who reported difﬁculties of handling were elderly
(median age, 67 years). Thus, before performing implanta-
tion, dyspraxia or the possibility of family members helping
with handling (as in the case of two of the patients in the
present series) need to be assessed.
Preoperative audiometry proved indispensable in UTD
patients with a healthy contralateral ear. In case of posi-
tive stereoaudiometry results, the satisfaction level will be
as high as in CHL patients. In the present series, one bor-
derline test was associated with a bad postoperative result,
while another bad test gave a reasonable result with satis-
faction scored at 7/10 although the patient (a child, who
disliked ﬁtting the HA even though he did ﬁnd improvement
withy it) seldom wore the BAHA. In CHL, BAHAs gave very
high levels of satisfaction. The risk of failure in this indica-
tion is thus very low, and implantation can be recommended
whenever tolerance for conventional HAs is lacking.
ConclusionBAHAs are effective, not bothersome, and well accepted by
the patient. Overall beneﬁt in terms of improved quality of
life was signiﬁcant in almost all cases, especially in CHL. In
fd hearing aid (BAHA) 111
ase of UTD, thorough preoperative assessment (audiometry
n noise, age, esthetic judgment, working conditions and
practical trial of the BAHA using a headband) is highly
dvisable before deciding on implantation, in order to obtain
he rate of success currently reported.
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ppendix A.
AHA questionnaire
Please take a few minutes to answer this questionnaire
efore your audiometric tests. It lets us assess your satis-
action with the hearing aid. This will help us weigh its pros
nd cons. Thank you for taking part in this study.
urname: First name:
Please circle the answer that best matches your case (just
ne answer per question)
1) How many days a week do you use your BAHA?
every day (7 days)
almost every day (5—6 days per week)
from time to time (3—4 days per week)
sometimes (1—2 days per week)
never
2) How many hours per day do you wear your BAHA?
more than 8 hrs per day
4 to 8 hrs per day
2 to 4 hrs per day
less than 2 hrs per day
3) Has your quality of life been improved by the BAHA?
yes
no
sometimes yes, sometimes no
no difference
4) Score your overall satisfaction or dissatisfaction with
he BAHA on the numerical scale.
10: very satisﬁed
9
8
7
6
5: no difference with or without BAHA
4
3
2
1: dissatisﬁedHow would you rate the usefulness of the BAHA in the
ollowing situations?
5) Discussion with a single person:
1—
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excellent
very good
moderate
bad
very bad
6) Discussion in a group:
excellent
very good
moderate
bad
very bad
7) Listening to music
excellent
very good
moderate
bad
very bad
8) Listening to radio or television
excellent
very good
moderate
bad
very bad
9) How do you ﬁnd the BAHA from an esthetic point of
iew?
a) Generally
very esthetic
discreet and not bothersome
not very discreet, bothersome
very bothersome
b) Compared to conventional hearing aids
nicer
less nice
no difference
10) How do you rate handling the BAHA (clipping it onto
he bone implant)?
very easy
easy
okay
difﬁcult
very difﬁcult
11) Which situation is the BAHA most useful in?in noise
in group
one-to-one
all these situations
[
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12) Which situation is the BAHA not useful in?
in noise
in group
one-to-one
always useful
13) Would you do it again if you had to?
yes
no
If you met any problems, don’t hesitate to ask. Thank you
or your contribution to the study.
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